
    
      This is a prospective, randomized controlled trial to assess the influence of use of
      angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) in
      the development of the Acute Kidney Injury in the postoperative period of cardiac surgery.
      Patients undergoing cardiac surgery at the Heart Institute (InCor) - Brazil, will be
      randomized and in accordance with a list of random numbers, generated by a computer program,
      will be allocated in one of the groups (GDT or standard).
    
  